Wednesday, 11 July 2012

Eli Lilly schizophrenia drug fails late-stage trial



(Reuters) - Eli Lilly and Co said on Wednesday its experimental schizophrenia drug known as mGlu2/3 did not work in a late stage clinical trial.





via Reuters: Health News Read More Here..

No comments:

Post a Comment